| Literature DB >> 35726278 |
Mirjam Limmer1, Markus de Marées2, Ralf Roth1.
Abstract
Purpose: Wearing compression garments is a commonly used intervention in sports to improve performance and facilitate recovery. Some evidence supports the use of forearm compression to improve muscle tissue oxygenation and enhance sports climbing performance. However, evidence is lacking for an effect of compression garments on hand grip strength and specific sports climbing performance. The purpose of this study was to evaluate the immediate effects of forearm compression sleeves on muscular strength and endurance of finger flexor muscles in sports climbers. Materials andEntities:
Keywords: compression garments; finger flexor muscles; hand grip strength; muscle oxygenation; near infrared spectroscopy; sport climbing
Year: 2022 PMID: 35726278 PMCID: PMC9206081 DOI: 10.3389/fphys.2022.888860
Source DB: PubMed Journal: Front Physiol ISSN: 1664-042X Impact factor: 4.755
FIGURE 1Experimental design.
Anthropometric data and climbing ability of male (n = 12) and female (n = 12) participants.
| Male ( | Female ( | |
|---|---|---|
| Age (years) | 30.0 ± 7.2 | 28.2 ± 6.2 |
| Body mass (kg) | 74.8 ± 10.2 | 59.4 ± 5.6 |
| Height (cm) | 180.8 ± 6.1 | 166.6 ± 5.8 |
| BMI (kg/m2) | 22.8 ± 2.3 | 21.4 ± 1.0 |
| Body fat (%) | 9.7 ± 3.7 | 16.5 ± 4.2 |
| CA (IRCRA) | 15.3 ± 1.6 | 14.3 ± 1.0 |
| Forearm circumference (cm) | 28.8 ± 1.9 | 24.6 ± 1.0 |
Note: Data is presented as mean ± standard deviation of the mean.
BMI, body mass index. Climbing ability (CA) is indicated according to the IRCRA (International Rock Climbing Research Association) scale. For further details see Section 2.
FIGURE 2Representative changes in tissue oxygen saturation (StO2), oxygenated (oxy[heme]), deoxygenated (deoxy[heme]), and total (total[heme]) [heme] during hand grip strength and endurance (A) and finger hang (B) measurements.
Performance outputs for intermittent hand grip strength and endurance measurements of female (n = 12), male (n = 12), and all (n = 24) participants.
| COMP | CON | PLAC |
| ηp 2 | ||
|---|---|---|---|---|---|---|
|
| female | 332.7 ± 51.5* | 344.2 ± 56.8* | 334.5 ± 48.1* |
| 0.542 |
| male | 485.8 ± 95.0 | 488.9 ± 97.0 | 496.0 ± 87.0 | |||
| all | 409.3 ± 108.2 | 416.5 ± 107.2 | 415.3 ± 107.4 | 0.442 | 0.036 | |
|
| female | 32.1 ± 7.0 | 30.1 ± 9.2 | 29.0 ± 9.6 | 0.764 | 0.004 |
| male | 29.3 ± 5.1 | 29.3 ± 4.7 | 30.3 ± 6.5 | |||
| all | 30.7 ± 6.2 | 29.7 ± 7.1 | 29.6 ± 8.1 | 0.695 | 0.016 | |
Note: Data are presented as mean ± standard deviation of the mean.
COMP, compression trial; CON, control trial; PLAC, placebo trial; Fmax, peak force; FI, fatigue index; asterisks (*) indicate significant differences compared to male participants.
p and ηp 2 indicate pairwise comparisons between female and male participants (“male”, “female”), and main treatment effects for the conditions COMP, CON, and PLAC (“all”). For further details see the Section 2.
FIGURE 3Near-infrared spectroscopy (NIRS) changes during hand grip strength and endurance measurements (n = 16) under compression (COMP), control (CON), and placebo (PLAC) conditions for: (A,B) tissue oxygen saturation (ΔStO2), (C,D) oxygenated (Δoxy[heme]), and (E,F) total (total [heme]) [heme]. Data points represent individual values (○). Bar charts are means ± SD. See the Section 2 for further details, *p < 0.05.
Near-infrared spectroscopy changes and pairwise comparisons during intermittent hand grip strength and endurance measurements of female (n = 10) and male (n = 6) participants.
| COMP | CON | PLAC |
| ηp 2 | |||
|---|---|---|---|---|---|---|---|
| ΔStO2 (%) | DeOxy | female | –3.4 ± 2.1 | –2.4 ± 1.9 | –3.2 ± 1.7 | 0.243 | 0.096 |
| male | –5.1 ± 2.3 | –3.6 ± 1.4 | –2.6 ± 0.7 | ||||
| ReOxy | female | 2.8 ± 1.6 | 1.8 ± 1.7 | 2.6 ± 1.4 | 0.200 | 0.114 | |
| male | 4.5 ± 1.9 | 3.0 ± 2.0 | 1.9 ± 0.7 | ||||
| Δoxy[heme] (μmol) | DeOxy | female | –10.0 ± 5.5 | –6.2 ± 5.9 | –7.5 ± 5.3 | 0.777 | 0.006 |
| male | –11.9 ± 5.5 | –8.0 ± 3.0 | –5.4 ± 1.3 | ||||
| ReOxy | female | 9.5 ± 5.5 | 5.8 ± 5.9 | 6.8 ± 5.1 | 0.863 | 0.002 | |
| male | 11.2 ± 5.4 | 7.3 ± 2.9 | 4.6 ± 1.1 | ||||
| Δtotal[heme] (μmol) | DeOxy | female | –6.6 ± 3.8 | –3.1 ± 5.3 | –2.1 ± 6.2 | 0.432 | 0.045 |
| male | –3.3 ± 11.3 | –1.9 ± 5.1 | –1.6 ± 4.5 | ||||
| ReOxy | female | 7.2 ± 4.7 | 3.7 ± 5.3 | 2.6 ± 6.3 | 0.493 | 0.034 | |
| male | 3.3 ± 10.7 | 2.7 ± 5.5 | 2.8 ± 4.7 | ||||
Note: Data are presented as mean ± standard deviation of the mean.
COMP, compression trial; CON, control trial; PLAC, placebo trial; StO2, tissue oxygen saturation; oxy[heme], oxygenated [heme]; Δ, mean decrease (DeOxy = deoxygenation) and increase (ReOxy = reoxygenation) from the contraction and release phases of hand grip measurement; p and ηp 2 indicate pairwise comparisons between female and male participants; For further details see the Section 2.
Time to failure and near-infrared spectroscopy changes during continuous finger hang tests of female (n = 12), male (n = 12), and all (n = 24) participants.
| COMP | CON | PLAC |
| ηp 2 | ||
|---|---|---|---|---|---|---|
| TTF (s) | female | 74.8 ± 23.8 | 73.6 ± 23.5 | 77.8 ± 19.7 | 0.882 | 0.001 |
| male | 75.3 ± 19.6 | 75.7 ± 16.6 | 79.0 ± 28.7 | |||
| all | 75.0 ± 21.4 | 74.7 ± 19.9 | 78.4 ± 24.1 | 0.327 | 0.049 | |
| ΔStO2 (%) | female | –19.9 ± 11.0 | –16.6 ± 7.9 | –18.4 ± 11.7 | 0.242 | 0.062 |
| male | –24.2 ± 10.7 | –22.2 ± 11.7 | –20.6 ± 11.2 | |||
| all | –22.0 ± 10.8 | –19.4 ± 10.2 | –19.5 ± 11.3 | 0.488 | 0.032 | |
| Δoxy[heme] (μmol) | female | –20.2 ± 12.0 | –19.4 ± 11.1 | –17.6 ± 11.5 | 0.313 | 0.046 |
| male | –25.2 ± 10.8 | –22.4 ± 13.6 | –21.7 ± 13.0 | |||
| all | –22.7 ± 11.5 | –20.9 ± 12.2 | –19.7 ± 12.2 | 0.512 | 0.030 | |
| Δtotal[heme] (μmol) | female | –1.9 ± 7.1 | –1.7 ± 6.2 | 2.0 ± 4.8 | 0.592 | 0.013 |
| male | –1.6 ± 8.0 | –1.7 ± 12.1 | –2.0 ± 11.3 | |||
| all | –1.7 ± 7.4 | –1.7 ± 9.4 | –0.0 ± 8.7 | 0.709 | 0.016 | |
Note: Data are presented as mean ± standard deviation of the mean.
COMP, compression trial; CON, control trial; PLAC, placebo trial; TTF, time to failure, StO2, tissue oxygen saturation; oxy[heme], oxygenated [heme]; Δ, decrease from the maximum concentrations at the beginning of the finger hang to the concentration at the time point of task failure; p and ηp 2 indicate pairwise comparisons between female and male participants (“male”, “female”), and main treatment effects for the conditions COMP, CON, and PLAC (“all”). For further details see the Section 2.
Lap climbing performance measurements of female (n = 12), male (n = 12), and all (n = 24) participants.
| COMP | CON | PLAC |
| ηp
2/ | ||
|---|---|---|---|---|---|---|
| LCT (s) | female | 484 ± 197 | 495 ± 218 | 575 ± 414 | 0.847 | 0.002 |
| male | 421 ± 133 | 584 ± 321 | 496 ± 203 | |||
| all | 452 ± 167 | 540 ± 272 | 535 ± 321 | 0.169 | 0.078 | |
| LCD (m) | female | 74.9 ± 42.7 | 72.7 ± 47.8 | 88.2 ± 82.2 | 0.502 | 0.021 |
| male | 74.6 ± 25.5 | 106.8 ± 55.5 | 91.9 ± 41.5 | |||
| all | 74.7 ± 34.4 | 89.7 ± 53.5 | 90.0 ± 63.7 | 0.188 | 0.073 | |
| Lamax (mmol/l) | female | 7.05 ± 2.29 | 7.77 ± 2.68 | 7.01 ± 2.15 | 0.391 | 0.034 |
| male | 7.71 ± 2.68 | 8.34 ± 2.55 | 8.01 ± 2.81 | |||
| all | 7.38 ± 2.02 | 8.05 ± 2.57 | 7.51 ± 2.50 | 0.245 | 0.062 | |
| RPE | female | 15.9 ± 2.3 | 16.2 ± 2.1 | 16.3 ± 2.0 | 0.395 | 0.033 |
| male | 16.8 ± 2.0 | 16.8 ± 1.4 | 16.6 ± 1.5 | |||
| all | 16.4 ± 2.1 | 16.5 ± 1.8 | 16.5 ± 1.7 | 0.950 | 0.002 | |
| VAS | female | 6.1 ± 1.7 | 6.3 ± 1.9 | 5.8 ± 1.9 | 0.964 | 0.000 |
| male | 6.3 ± 1.7 | 6.0 ± 1.6 | 5.8 ± 1.6 | |||
| all | 6.2 ± 1.7 | 6.2 ± 1.7 | 5.8 ± 1.7 | 0.431 | 0.035 | |
Note: Data is presented as mean ± standard deviation of the mean.
COMP, compression trial; CON, control trial; PLAC, placebo trial; LCT, lap climbing time; LCD, lap climbing distance; Lamax, maximum blood lactate concentration; RPE, Borgs’ rate of perceived exertion; VAS, visual analog scale; p and ηp 2 indicate pairwise comparisons between female and male participants (“male”, “female”), and main treatment effects for the conditions COMP, CON, and PLAC (“all”). For further details see the Section 2.